Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02878850 · ClinicalTrials.gov registry record · NA
Randomized Trial of Early Hemodynamic Management of Patients Following Acute Spinal Cord Injury
A NA study of Spinal Cord Injury, sponsored by Oregon Health and Science University.
- Completed
- Registry status
- NA
- Development phase
- 94
- Enrollment target
- 11
- Study locations
NCT02878850: Completed NA study of Spinal Cord Injury, sponsored by Oregon Health and Science University.
NCT02878850 is a NA study of Spinal Cord Injury that has completed, run by Oregon Health and Science University. The registered enrollment target is 94 participants, above the 85-participant average among 99 other Spinal Cord Injury trials with a reported enrollment target (11% higher). The trial reports 11 study locations across 8 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02878850, a NA study of Spinal Cord Injury, has completed, sponsored by Oregon Health and Science University.
- COMPLETED
- Registry status
- NA
- Development phase
- 94 participants
- Enrollment target
- 11
- Study locations
Study Summary
The purpose of this study is to learn more about how participants heal from acute spinal cord injury.
Primary Outcome
Change from baseline in ASIA Upper Extremities Motor Score (UEMS), comparing patients maintained at a MAP target between 65 and 70 mm Hg, and patients maintained at a MAP target between 85 and 90 mm Hg for a duration of seven days or until ICU discharge. The UEMS score ranges from 0 to 50, with 50 indicating no deficits.
Conditions Studied
Interventions
- OTHER Augmented Blood Pressure
Study Locations (11)
Pennsylvania
- University of Pennsylvania Health System - Philadelphia
- Thomas Jefferson University - Philadelphia
- University of Pittsburgh Medical Center - Pittsburgh
North Carolina
- Atrium Health F.H. Sammy Ross Trauma Center - Charlotte
- Atrium Health Wake Forest Baptist - Winston-Salem
California
- University of Southern California - Los Angeles
Connecticut
- Yale University - New Haven
Kansas
- University of Kansas Medical Center - Kansas City
Maryland
- University of Maryland Medical Center - Baltimore
Ohio
- University of Cincinnati Medical Center - Cincinnati
Oregon
- Oregon Health & Science University - Portland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 94 participants |
| Start Date | 2017-05-22 |
| Est. Completion | 2023-07-26 |
| Phase | NA |
What the finished NCT02878850 record still lists
NCT02878850 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 94 participants, a relatively small participant target, above the 85-participant average among 99 other Spinal Cord Injury trials with a reported enrollment target (11% higher).
The record links to 1 condition, with Spinal Cord Injury appearing as the primary indexed condition, and to 1 intervention - of which Augmented Blood Pressure is the first listed.
NCT02878850 lists 11 locations in 8 states (Pennsylvania, North Carolina, California).
Frequently Asked Questions
What is clinical trial NCT02878850 about?
NCT02878850 is a clinical study titled "Randomized Trial of Early Hemodynamic Management of Patients Following Acute Spinal Cord Injury". The purpose of this study is to learn more about how participants heal from acute spinal cord injury.
What is the current status of trial NCT02878850?
This trial is currently completed. It is a NA study. The enrollment target is 94 participants. The study started on 2017-05-22. Estimated completion is 2023-07-26.
What conditions does trial NCT02878850 study?
This clinical trial studies the following conditions: Spinal Cord Injury.
What interventions are being tested in trial NCT02878850?
The interventions under investigation include: Augmented Blood Pressure (OTHER).
Who is sponsoring clinical trial NCT02878850?
This trial is sponsored by Oregon Health and Science University, which has 546 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02878850 being conducted?
This trial has 11 study locations across California, Connecticut, Kansas, Maryland, North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Spinal Cord Injury
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02878850's enrollment target sits among peer trials
94 19th of 99 higher than 80 of 99 other Spinal Cord Injury trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Spinal Cord Injury trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Cortical Recording and Stimulating Array Brain-Machine Interface
RECRUITING · NA
-
Clinical Outcome Assessment for AT & BCI
RECRUITING · NA
-
Motoneuron Recruitment and Motor Evoked Potential Up-Conditioning (MEP) in Spinal Cord Injury (SCI)
RECRUITING · NA
-
SCI&U Peer Health Coaching Program for Individuals Newly Discharged From Inpatient Rehabilitation
RECRUITING · NA
-
At-Home Genital Nerve Stimulation for SCI Bowel
RECRUITING · NA
-
Exoskeleton and Spinal Cord Stimulation for SCI
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03747146 · 94 participants · NA
Enhanced Recovery After Surgery (ERAS) Total Knee Replacement (TKR) With a Transitional Pain Service
- NCT04061421 · 94 participants · Phase 1
Active Myeloid Target Compound Combinations in MDS/MPN Overlap Syndromes Overlap Syndromes (ABNL-MARRO)
- NCT04205968 · 94 participants · Phase 2
Ramucirumab and Paclitaxel or FOLFIRI in Advanced Small Bowel Cancers
- NCT04464759 · 94 participants · Phase 1
A Study of Nivolumab and Hydroxychloroquine or Nivolumab/Ipilimumab and Hydroxychloroquine in Advanced Melanoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI